GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...
Forbes contributors publish independent expert analyses and insights. Monica is an entertainment reporter covering TV, film, and music.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback